drugset / Trial / NCT07140510
Dinalbuphine Sebacate in Postoperative Pain Control After TKA
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the effectiveness of Dinalbuphine Sebacate for controlling subacute pain after total knee arthroplasty
Timeline
- Start
- 2025-10
- Primary completion
- 2026-06
- Completion
- 2026-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dinalbuphine sebacate | Small molecule | 150 mg | Intramuscular |